Holen Sie sich die Stockscreener-App
1.80
0.55%
-0.01
Finanzdaten der Caribou Biosciences Inc-Aktie (CRBU)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
31.73%
2.429
|
3.558 | 23.66 | 3.755 | 3.502 |
Operating Expenses
|
18.12%
48.43
|
41.00 | 38.30 | 36.62 | 34.62 |
| Benefits Costs and Expenses |
15.30%
43.66
|
37.87 | - | - | 31.55 |
| Costs And Expenses |
15.30%
43.66
|
37.87 | 38.30 | 36.62 | 31.55 |
| Operating Income/Loss |
22.86%
-46.00
|
-37.44 | -14.63 | -32.87 | -31.12 |
| Nonoperating Income/Loss |
52.33%
4.768
|
3.13 | 4.631 | 3.349 | 3.072 |
| Income/Loss From Continuing Operations Before Tax |
20.17%
-41.23
|
-34.31 | 23.66 | -29.52 | -28.04 |
| Income Tax Expense/Benefit |
100.00%
-
|
0.193 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
19.50%
-41.23
|
-34.51 | -10.00 | -29.52 | -28.04 |
|
Net Income/Loss
|
19.50%
-41.23
|
-34.51 | -10.00 | -29.52 | -28.04 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1,712%
89.30
|
4.9287 | 83.78 | 61.42 | 61.19 |
| Diluted Average Shares |
1,712%
89.30
|
4.9287 | 83.78 | 61.42 | 61.19 |
| Basic Earnings Per Share |
15.00%
-0.46
|
-0.40 | -0.12 | -0.48 | -0.46 |
| Diluted Earnings Per Share |
15.00%
-0.46
|
-0.40 | -0.12 | -0.48 | -0.46 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):